Non-Billable / Non-Specific Code
ICD-10-CM D46 is the diagnosis code for Myelodysplastic syndromes. This code falls under the section "Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes" within Chapter 2 â Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions are not included in D46. If the patient has both, code each condition separately:
Understanding where D46 sits in the ICD-10-CM classification helps ensure proper coding:
No, D46 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D46 is the ICD-10-CM diagnosis code for "Myelodysplastic syndromes". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
D46 is located in Section D37-D48 â "Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes" within Chapter 2 of the ICD-10-CM Tabular List.
D46 has 9 sub-code(s) that provide more specific detail: D46.0, D46.1, D46.2, D46.4, D46.9 and more.
Use D46 when the patients documented diagnosis matches "Myelodysplastic syndromes" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Myelodysplastic syndromes is D46.
No, D46 is non-billable. Use a more specific sub-code for primary diagnosis billing.
D46 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D46 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.